about
Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance.Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.Added value of arterial enhancement fraction color maps for the characterization of small hepatic low-attenuating lesions in patients with colorectal cancer.Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans.Update on the role of imaging in management of metastatic colorectal cancerCharacterization of focal liver lesions with contrast-enhanced ultrasound.Magnetic resonance imaging findings in primary lymphoma of the liver: a case report.Systemic treatment in breast cancer: a primer for radiologistsDefining the Modalities of Intravenous Contrast Application During the Diagnostics of Hepatic Metastases with Computerized Tomography.Surgical therapy for colorectal metastases to the liver.Application of heat-damaged Tc-99m RBCs in a patient with suspected hepatic metastasis.MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.Fast low-angle positive contrast steady-state free precession imaging of USPIO-labeled macrophages: theory and in vitro experiment.Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.Imaging diagnosis of colorectal liver metastasesRare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature.Solid liver masses: approach to management from the standpoint of a radiologist.Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know.An overview of imaging techniques for liver metastases management.Automated method for detection and segmentation of liver metastatic lesions in follow-up CT examinationsHepatic segmental atrophy and nodular elastosis: imaging features.A data-driven statistical model that estimates measurement uncertainty improves interpretation of ADC reproducibility: a multi-site study of liver metastases.Cystic tumors of the liver: a practical approach.90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging.Major pancreatic resections: normal postoperative findings and complications.Interactions between iodinated contrast media and tissue plasminogen activator: In vitro comparison study.Quantitative liver lesion volume determination by nanoparticle-based SPECT.CT features of hepatic metastases from hepatoid adenocarcinoma.Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.Comparison of tumor vascularity and hemodynamics in three rat hepatoma models.Imaging of pathology involving the space around the hepatic veins: "perivenous pattern".
P2860
Q30433231-BC9B084F-0474-437D-9FC5-E56B49F483D9Q30455431-EA929D2A-0EA9-4218-93F2-9669F83A683FQ35112515-7AE5F408-9F05-4978-BDB3-FE60DAFEE002Q35175972-AFA5B0F6-8346-40E9-BD9E-37E10571F82CQ35285305-ABB4352A-BED1-4D6D-AB56-1142381D741CQ35688715-008140D2-9F0C-47C9-B9E3-12F77AE81430Q36311955-4B6F72A7-DEDD-4C99-A07B-6A65171691DDQ36510679-8B1B6FF3-82BC-4D04-B99B-7D387301169AQ36681595-2D10CD9D-BBE0-49C5-A2D5-25960CEFAED3Q36832322-4DBF6CDE-4BDE-471A-A346-F8E3259F69E1Q36987420-ECC39F80-269C-4969-A17F-45CD343591BBQ37329995-4B409D9D-FB81-4E2C-8349-A4D00FEC8A30Q37370204-F3CD23B1-EEA6-4C74-B183-9B07A2333BABQ37624368-030C7236-9C22-43DE-86F9-1F28CD853141Q37969750-EC2FAFD6-B154-4FF9-B095-8A964F3B4ACBQ38016333-843A5129-FB0D-416F-ACCE-8539313DE833Q38163485-65B7EC00-45F5-4F7A-823C-FB408EF98E67Q38551081-73D4C627-F683-44BB-BC64-9374C5E519F4Q38594431-934ED3F4-8350-42A5-AB7C-C26885E79838Q39107086-2A532499-552B-4492-86D0-3E2877ABA89EQ39272653-5199173B-04E7-4E8A-93D3-66E2E6C43EA4Q42620668-61A74D89-3D73-4C37-9129-E17BD0BF5870Q42669888-8A049B92-F134-4521-BBC5-43353DB23182Q46385098-5626E2E9-56D6-4643-BB1A-EE9CBE973E61Q46923851-53B8AA70-BB63-4E42-ACE6-71B5068FD639Q49946848-B592705F-A6B2-4F73-92CF-A5146602FE20Q50753151-E6F7E4D8-409A-48A1-964F-208C40441655Q53096860-EAB646B4-720F-4D39-981F-78E5E44F26EBQ53114076-FF9C0874-7217-4250-BFAB-B1C5BB542CC2Q53170580-F78571DE-7A74-4CAB-91B1-076890815778Q53179915-EAE3027F-81F3-4489-B394-DC6880E332EAQ55069990-AC59ABEC-FCEA-490A-A901-0AC826505FAA
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
CT and MR imaging of hepatic metastases.
@ast
CT and MR imaging of hepatic metastases.
@en
type
label
CT and MR imaging of hepatic metastases.
@ast
CT and MR imaging of hepatic metastases.
@en
prefLabel
CT and MR imaging of hepatic metastases.
@ast
CT and MR imaging of hepatic metastases.
@en
P2093
P1476
CT and MR imaging of hepatic metastases.
@en
P2093
P304
P356
10.2214/AJR.174.3.1740691
P407
P577
2000-03-01T00:00:00Z